- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00885768
Prevalence of Renal Artery Stenosis in Patients Referred for Cardiac Catheterization (RAS)
May 11, 2011 updated by: Imam Khomeini Hospital
Prevalence of Renal Artery Stenosis in Patients Refered for Cardiac Catheterization to Heart Center Hospital in July-September 2008
All patients referred for coronary angiography will simultaneously be evaluated for renal artery stenosis and then stenosis more than 50% will be analyzed according to clinical conditions, risk factors and lab data.
Study Overview
Detailed Description
Renal Artery Stenosis (RAS) is a common finding in patients with generalized atherosclerosis.
It is the cause of 15-20% of end stage renal disease in elderly patients.
The prevalence of asymptomatic RAS in general population is unknown but it estimated to be 18% in 7th decade and more than 50% in the 8th.
It is critical to find and manage the RAS before it's symptoms appear.
The Gold standard for diagnosis of atherosclerotic arterial stenosis is angiography.
In this study we will evaluate the prevalence, severity, location and related factors to renal artery stenosis in patients whom referred for coronary angiography in period of July-September in one of the most referral heart center in Iran, "The Tehran heart center" which is doing more than 50 coronary angiography daily.
Study Type
Observational
Enrollment (Actual)
146
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tehran, Iran, Islamic Republic of
- Tehran Heart Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients reffered to the Tehran Heart center for coronary angiography
Description
Inclusion Criteria:
- age more than 18 years
Exclusion Criteria:
- contraindication to contrast use
- not signing consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
A
patients with renal artery stenosis
|
all patients undergoing coronary angiography with VISIPAQUE and if they had coronary stenosis then renal artery angiography will be done.
the dose of contrast will be chosen according to renal function and clinical conditions which will be varied from 75 to 300 ml.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of Renal Artery Stenosis (RAS)
Time Frame: 2 months
|
2 months
|
|
The Number of Patients With Renal Artery Stenosis
Time Frame: 3months
|
the prevalence of renal artery stenosis in patients with coronary artery disease
|
3months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2008
Primary Completion (Actual)
September 1, 2008
Study Completion (Actual)
April 1, 2009
Study Registration Dates
First Submitted
July 11, 2008
First Submitted That Met QC Criteria
April 21, 2009
First Posted (Estimate)
April 22, 2009
Study Record Updates
Last Update Posted (Estimate)
May 13, 2011
Last Update Submitted That Met QC Criteria
May 11, 2011
Last Verified
April 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RAS001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Artery Stenosis
-
Adriano Henrique Pereira BarbosaCompletedTransplant Renal Artery StenosisBrazil
-
Guang'anmen Hospital of China Academy of Chinese...UnknownAtherosclerotic Renal Artery StenosisChina
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and other collaboratorsRecruitingHeart Failure | Percutaneous Transluminal Angioplasty | Renovascular Hypertension | Renal Artery Stenosis Atherosclerotic | Renovascular Hypertension With Renal FailureDenmark
-
Mayo ClinicCompletedAtherosclerotic Renal Artery Stenosis | Ischemic Nephropathy | Renovascular HypertensionUnited States
-
Imperial College Healthcare NHS TrustRecruitingTransplant Renal Artery StenosisUnited Kingdom
-
Peking Union Medical College HospitalUnknownA Study of Using Parenchymal Blood Volume(PBV) for Endovascular Treatment of Renal Arterial StenosisRenal Artery Stenosis | Renal Blood PerfusionChina
-
Peking University First HospitalRecruitingRenal Artery Stenosis Atherosclerotic | Secondary Hypertension Renal ArterialChina
-
Chinese Academy of Medical Sciences, Fuwai HospitalNot yet recruitingRenal Artery Obstruction | Hypertension, RenovascularChina
-
Atrium Medical CorporationCompletedHypertension, Renovascular | Renal Artery StenosisUnited States
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceTerminatedHypertension | Hypertension Resistant to Conventional Therapy | Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 PercentFrance
Clinical Trials on angiography
-
Institute for Clinical Evaluative SciencesCompleted
-
University of LeipzigStiftung Institut fuer HerzinfarktforschungWithdrawnNon-ST-elevation Myocardial InfarctionGermany
-
Heidelberg Engineering GmbHCompletedNormal Eyes | Retinal VascularUnited States
-
St. Olavs HospitalNorwegian University of Science and Technology; Helse Nord-Trøndelag HF; Alesund... and other collaboratorsRecruitingNon-ST Elevated Myocardial InfarctionNorway
-
Hospital San Carlos, MadridHospital General Universitario Gregorio Marañon; Hospital Clinic of Barcelona; Germans Trias i Pujol Hospital and other collaboratorsCompleted
-
Johns Hopkins UniversityCanon Medical Systems, USARecruitingCoronary Artery DiseaseUnited States
-
Assiut UniversityCompleted
-
China National Center for Cardiovascular DiseasesActive, not recruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Coronary Stenosis | Myocardial Ischaemia | Coronary CirculationChina
-
University Hospital Schleswig-HolsteinDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)CompletedOut-of-hospital Cardiac ArrestGermany
-
Clinical Research Office Imaging DivisionCompletedAortic Aneurysm, AbdominalNetherlands